Thus the conclusion of the Stenner-Liewen group that daily pomegranate intake has no impact on PSA levels in patients with advanced prostate cancer is wrong since it was based on an inadequate amount of coactive ingredients in their pomegranate mixture. This evidence concerns the gene KLK3 and Familial prostate cancer.